首页> 外文OA文献 >Aica Orotate, a Nucleic Acid Precursor, in the Treatment of Male Sterility
【2h】

Aica Orotate, a Nucleic Acid Precursor, in the Treatment of Male Sterility

机译:Aica Orotate,一种核酸前体,用于治疗男性不育症

摘要

AICA orotate (AICAMIN), a nucleic acid precursor, was u sed for the treatment of male sterility. Therapy with AICAMIN in doses of 600 mg/day administered orally was carried out for 4-10 weeks. 1. Of 10 cases of oligozoospermia, 6 showed an increase in sperm counts and 4 were irresponsive to the treatment. Sperm motility was slightly improved in 6 cases. 2. In all 4 cases of azoospermia treated, spermia did not appear in the seminal fluid. 3. Of the 4 cases of necrozoospermia and asthenozoospermia, 1 showed a m oderate increase in motility of the sperm and 3 were irresponsive to the treatment. 4. Five cases of oligozoospermia were treated with a com bination of AICAMIN and gonadotropic hormone preparations. The result was that the number of the sperm increased in all cases. The effect of this agent was remarkable especially in 2 cases. 5. No changes were observed in urinary 17-KS, urinary gonadotropin , and plasma cholesterol values before and after the administration of AICAMIN.
机译:核酸前体AICA乳清酸酯(AICAMIN)用于治疗男性不育症。口服600毫克/天的AICAMIN治疗进行了4-10周。 1.在10例少精子症患者中,有6例精子数量增加,而4例对该治疗无反应。 6例精子活动力略有改善。 2.在所有4例无精症患者中,精液中未出现精子。 3.在4例坏死精子症和弱精子症中,有1例显示精子活力增加,其中3例对治疗无反应。 4. 5例少精症患者用AICAMIN和促性腺激素制剂联合治疗。结果是在所有情况下精子的数量都增加了。该药的效果显着,特别是在2例中。 5.在服用AICAMIN之前和之后,尿17-KS,尿促性腺激素和血浆胆固醇值均未见变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号